Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study

Regular blood transfusion is the mainstay of treatment in transfusion-dependent β-thalassemia (TDT); however, transfusions culminate in an array of serious complications. Therefore, a single-arm, non-randomized clinical trial was conducted in hydroxyurea refractory TDT patients to explore the long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Zahid, Ismail, Mohammad, Rehman, Inayat Ur, Rani, Gulab Fatima, Ali, Muhammad, Khan, Muhammad Tariq Masood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442319/
https://www.ncbi.nlm.nih.gov/pubmed/37604857
http://dx.doi.org/10.1038/s41598-023-40849-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442319/
https://www.ncbi.nlm.nih.gov/pubmed/37604857
http://dx.doi.org/10.1038/s41598-023-40849-4

Ejemplares similares